There are 9 papers on clostridium difficile infection in aging research: 1 trial and 6 observational studies in people, 2 reviews.
9 papers study it15 more mention it7 findings
See all 24 papers on clostridium difficile infection
“1-year mortality rates (48.2% vs 31.1%, P < 0.001) were significantly higher among the CDI residents vs non-CDI residents.”
- Human trial1
- Humans6
Interventions
1Fecal microbiota transplantation
downin humans1
1 study
Fecal microbiota transplantation
downin humans1
Fecal microbiota transplantation protects against clostridium difficile infection in humans.
“The innovation in GM dysbiosis is intervention by Fecal Microbiota Transplantation (FMT), which has been confirmed as a therapy for recurrent Clostridium difficile infections”
Review
Biogerontology
Upstream
1C. difficile toxin-specific antibody
downin humans1
1 study
C. difficile toxin-specific antibody
downin humans1
C. difficile toxin-specific antibody protects against clostridium difficile infection in humans.
“C. difficile toxin-specific antibody response protects the host against initial and recurrent infections”
Review
The journals of gerontology. Series A, Biological sciences and medical sciences
Associations
4Mortality
upin humans2
2 studies
Mortality
upin humans2
Clostridium difficile infection is associated with mortality in humans (US nursing home residents; propensity score matched comparison) (1-year mortality: 48.2% vs 31.1%; P < 0.001).
“1-year mortality rates (48.2% vs 31.1%, P < 0.001) were significantly higher among the CDI residents vs non-CDI residents.”
HumansUS nursing home residents; propensity score matched comparison30 days to 1 year
BMC geriatrics
Clostridium difficile infection is associated with mortality in humans (propensity-adjusted comparison of CDI and non-CDI Medicare patients) (42.6% vs 23.4%).
“CDI was associated with near doubling of both mortality (42.6% vs 23.4%, P<.001) and total healthcare costs”
Humanspropensity-adjusted comparison of CDI and non-CDI Medicare patients12 months
Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States
Infection control and hospital epidemiology
Total health care costs
upin humans1
1 study
Total health care costs
upin humans1
Clostridium difficile infection is associated with total health care costs in humans (US nursing home residents; propensity score matched comparison) ($28,621 vs $13,644; P < 0.001).
“Total health care costs within 2 months following the first CDI episode were also significantly higher for CDI residents ($28,621 vs $13,644, P < 0.001).”
HumansUS nursing home residents; propensity score matched comparison2 months following the first CDI episode
BMC geriatrics
Total healthcare costs
upin humans1
1 study
Total healthcare costs
upin humans1
Clostridium difficile infection is associated with total healthcare costs in humans (propensity-adjusted comparison of CDI and non-CDI Medicare patients) ($64,807±$66,480 vs $38,128±$46,485).
“CDI was associated with near doubling of both mortality (42.6% vs 23.4%, P<.001) and total healthcare costs ($64,807±$66,480 vs $38,128±$46,485, P<.001).”
Humanspropensity-adjusted comparison of CDI and non-CDI Medicare patients12 months
Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States
Infection control and hospital epidemiology
Antibiotic therapy
upin humans1
1 study
Antibiotic therapy
upin humans1
Antibiotic therapy is associated with clostridium difficile infection in humans.
“The impact of antibiotic therapy on the increased incidence of CDI was clearly confirmed in our study group when examining patients' histories.”
HumansHospitalized patients with confirmed CDI; antibiotic exposure assessed from patient historiesn = 235
Can we improve the therapy of Clostridium difficile infection in elderly patients?
Wiener klinische Wochenschrift
Trial sponsors
Company4 trialsPhase 31,348 people
Company3 trialsPhase 31,424 people
Company1 trialPhase 2272 people
Company1 trialPhase 2100 people
Company1 trialPhase 253 people
Company1 trialPhase 118 people
1 trialPhase 41,294 people
1 trialPhase 4151 people
Funding
1 grant since 2019National Institute on Aging$640K